Recently stock market analysts have updated their consensus ratings on shares of Ameren Corporation (NYSE:AEE). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/04/2016 – Ameren Corporation was downgraded to “hold” by analysts at Argus. They now have a USD 52 price target on the stock.

04/04/2016 – Ameren Corporation was upgraded to “overweight” by analysts at Barclays. They now have a USD 55 price target on the stock.

08/03/2015 – Ameren Corporation was upgraded to “outperform” by analysts at Wolfe Research.

07/28/2015 – Ameren Corporation was upgraded to “neutral” by analysts at Goldman Sachs.

05/14/2015 – Ameren Corporation was downgraded to “hold” by analysts at Zacks.

05/11/2015 – Ameren Corporation had its “neutral” rating reiterated by analysts at UBS. They now have a USD 41 price target on the stock.

09/24/2014 – Ladenburg Thalmann began new coverage on Ameren Corporation giving the company a “buy” rating. They now have a USD 42 price target on the stock.

05/09/2014 – Ameren Corporation had its “neutral” rating reiterated by analysts at Evercore ISI. They now have a USD 40 price target on the stock.

05/09/2014 – Ameren Corporation was downgraded to “equal weight” by analysts at Morgan Stanley.

03/03/2014 – Ameren Corporation was upgraded to “buy” by analysts at Thomson Reuters/Verus.

01/06/2014 – Ameren Corporation was upgraded to “outperform” by analysts at Wells Fargo.

Ameren Corporation has a 50 day moving average of 48.66 and a 200 day moving average of 45.57. The stock’s market capitalization is 11.69B, it has a 52-week low of 37.26 and a 52-week high of 51.06.

The share price of the company (NYSE:AEE) was down -1.41%, with a high of 48.83during the day and the volume of Ameren Corporation shares traded was 1599108.

View other investors thoughts on Ameren Corporation with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.